Professional Supplier of Nano-Targeted Drug Scientific Research Products

APIs & Intermediates

Carfilzomib-d8 | CAS 1537187-53-3

Catalog: TASK-37-1000208   CAS NO.: 1537187-53-3
Delivery Fill in your shipping address to check the estimated shipping fee of your order

Select Shipping Address

$0.00 delivery Normal Delivery(7Days) Details Cyprum itidem insulam procul a continenti

$0.00 delivery Express Delivery Details Cyprum itidem insulam procul a continenti

  • High Quality Products
  • Fast and Safe Delivery

Description

Carfilzomib-d8 ((αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8 / (αS)-α-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8 / PR 171-d8) is a deuterated form of Carfilzomib, a potent proteasome inhibitor used in cancer therapy. The deuterium (d8) labeling indicates that eight hydrogen atoms in the Carfilzomib molecule have been replaced with deuterium, a stable isotope of hydrogen. Carfilzomib is a specific proteasome inhibitor used in treating multiple myeloma. The deuterated version can be used to study the detailed mechanisms of proteasome inhibition and the drug’s interaction with its target. Carfilzomib-d8 can also be used to investigate how Carfilzomib interacts with other drugs. By tracking the deuterated form, researchers can differentiate between Carfilzomib and other drugs in complex mixtures. This product is available in kilograms. Please kindly contact us if you are in request.

Specifications

CAS No.1537187-53-3
FormulaC40H49D8N5O7
Molecular Weight727.96
Purity>98%
Ship Within1 week
Storage Temp.-20℃
Shipping4-25℃ for up to 3 weeks
Welcome to Taskcm

This email already exists.

Username already exists.

Please confirm the password is the same.

or